Victorian Infectious Diseases Reference Laboratory

2006

Antiviral drug resistance: clinical consequences and molecular aspects.

Bartholomeusz A and Locarnini SA.
Semin Liver Dis 2006; 26(2):162-170

Hepatitis B virus mutations associated with antiviral therapy.

Bartholomeusz A and Locarnini S.
J Med Virol 2006; 78 Suppl 1:S52-55.

Serological and molecular diagnosis.

Bowden S
Semin Liver Dis 2006; 26:97-103.

Molecular diagnostics in hepatitis B.

Bowden S, Locarnini S.
Chapter 53. In: Principles of Molecular Medicine 2006, 2nd edition, eds Runge MS, Patterson C. Humana Press, Totowa, NJ.

Chronic hepatitis C virus infection: genotyping and its clinical role.

Bowden DS, Berzsenyi DM.
Future Microbiol 2006; 1:103-112.

Annual report of the Australian National Poliovirus Reference Laboratory 2005.

Brussen KA, Roberts J, Ibrahim A, Stambos V, Thorley BR.
Commun Dis Intell. 2006;30(3):334-40.

Undiagnosed and potentially lethal parasitic infections among immigrants to Australia.

Caruana SR, Kelly H, Ngeow JYY, Ryan N, Bennett C, Skull SA, Biggs BA.
J Travel Med 2006; 13:231-239.

Analysis of human coronavirus 229E spike and nucleoprotein genes demonstrates a genetic shift between chronologically distinct strains.

Chibo D and Birch C.
Journal of General Virology 2006; 87:1203-1208.

Comparisons of influenza and influenza like illness data sources in Victoria for seasonal and pandemic surveillance.

Clothier H, Aitkin L, Turner J, Sundararajan, Kelly H.
Commun Dis Intell 2006; 30:345-349.

Geographic representativeness for sentinel influenza surveillance: implications for routine surveillance and pandemic preparedness.

Clothier H, Turner J, Hampson A, Kelly H.
Aust NZ J Public Health 2006; 30:337-341.

Is there an optimal genetic target for molecular analysis of hepatitis B virus transmission?

Cowie BC.
Journal of Clinical Microbiology 2006; 44 (8): 3051

Evaluation of the Dako IDEIA norovirus EIA assay for detection of norovirus using faecal specimens from Australian gastroenteritis outbreaks.

Dimitriadis A, Bruggink L D, Marshall J A.
Pathology 2006; 38:157-167.

Re-emerging poliomyelitis – is Australia’s surveillance adequate?

Durrheim D, Massey P, Kelly H.
Commun Dis Intell 2006; 30:275-277.

Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set.

Filliol I, Motiwala AS, Cavatore M, Qi W, Hazbon MH, Bobadilla del Valle M, Fyfe J, Garcia-Garcia L, Rastogi N, Sola C, Zozio T, Guerrero MI, Leon CI, Crabtree J, Angiuoli S, Eisenach KD, Durmaz R, Joloba ML, Rendon A, Sifuentes-Osornio J, Ponce de Leon A, Cave MD, Fleishmann R, Whittam TS, Alland D. (2006)
J Bacteriol. 188(2):759-772.

Chronic hepatitis B: current testing strategies.

Gish RG and Locarnini SA.
Clin Gastroenterol Hepatol 2006; 4(6):666-676.

Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis

Gordon A, Hobbs DA, Bowden DS, Bailey MJ, Mitchell J, Francis AJP, Roberts S.
C. J Gastro Hepatol 2006; 21:275-280.

Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

Hazbon MH, Brimacombe M, Bobadilla del valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, Garcia-Garcia L, Leon CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de Leon A, Alland D. (2006)
Antimicrob Agents Chemother. 50(8):2640-2649.

Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy.

Hui, CK, Bowden S, Zhang HY, Wong A, Lewin S, Rousseau F, Mommeja-Marin H, Lee NP, Luk JM, Locarnini S, Leung N, Naoumov NV, Lau,GK.
J Clin Microbiol 2006; 44(8):2983-2987.

Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer ) in Victoria, Australia.

Johnson PDR, Hayman JA, Quek TY, Fyfe J, Jenkin GA, Buntine JA, Athan E, Birrell M, Johnstone B, Graham J, Lavender CJ. (2007)
MJA 186: 64-68.

Parasite specific IgG response and peripheral blood eosinophil count following abendazole treatment for presumed chronic strongyloides.

Karunajeewa H, Kelly H, Leslie D, Leydon J, Tobin S, Sakayo P, Biggs BA.
J Travel Med 2006; 13:84-91.

SARS-associated coronavirus replication in cell lines.

Kaye M, Druce J, Tran T, Kostecki R, Morris J, Catton M, Birch C.
Emerging Infectious Diseases 2006; 12:128-133.

Polioviruses and other enteroviruses isolated from faecal samples of patients with acute flaccid paralysis in Australia, 1996-2004.

Kelly H, Brussen KA, Lawrence A, Elliot E, Pearn J, Thorley B.
J Paediatr Child Health 2006; 42:370-376.

Evidence that the association between oral poliovirus vaccine and transverse myelitis may be causal: a case history and review of the literature.

Kelly H.
J Paediatr Child Health 2006; 42:155-159.

Toll-like receptor expression in chronic hepatitis C: Correlation with pro-inflammatory cytokine levels and liver injury.

Kurtovic J, Skinner N, Riordan SM, Locarnini S, McIver CJ, Williams R, Visvanathan K.
Inflamm. Res 2006; 55:279-285

First case of Mycobacterium ulcerans disease (Bairnsdale ulcer) in New South Wales.

Lavender CJ, Senanayake SN, Fyfe JA, Buntine JA, Globan M, Stinear T, Hayman JA, Johnson PD. (2007)
MJA 186: 62-63.

Development of a real-time PCR assay to detect Treponema pallidum in clinical specimens and assesssment of the assay’s performance by comparison with serological testing.

Leslie DE, Azzato F, Karapanagiotidis T, Leydon J, Fyfe J. (2007)
J Clin Microbiol 45: 93-96

A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B.

Lim SG, Wai CT, Lee YM, Dan YY, Sutedja DS, Wee A, Suresh S, Wu YJ, Machin D, Lim CC, Fock KM, Koay E, Bowden S, Locarnini S, Ishaque SM.
Antivir Ther 2006; 11: 245-253.

Cellular and virological mechanisms of HBV drug resistance.

Locarnini S and Mason WS.
J Hepatol 2006; 44:422-431.

Molecular virology of hepatitis B virus and the development of antiviral drug resistance.

Locarnini S and Omata M.
Liver Int 2006; 26(S2):11-22.

Laboratory diagnosis of norovirus.

Marshall JA and Bruggink LD.
Clinical Laboratory 2006; 52:571-581.

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.

Matthews GV, Bartholomeusz A, Locarnini S, Ayres A, Sasaduesz J, Seaberg E, Cooper DA, Lewin S, Dore GJ, Thio CL.
Aids 2006; 20:863-870.

The clinical virology of hepatitis B.

Revill P and Locarnini S.
Future Virology 2006; 1(3)349-360.

Corchorus yellow vein virus, a New World geminivirus from the Old World.

Ha C, Coombes S, Revill P, Harding R, Vu M and Dale J.
J. Gen. Virol 2006; 87:997-1003.

Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B.

Riordan SM., Skinner N, Kurtovic J, Locarnini S, Visvanathan K.
Clin Vaccine Immunol 2006; 13(8):972-974.

HBV drug resistance: mechanisms, detection and interpretation.

Shaw T, Bartholomeusz A, Locarnini S.
J Hepatol 2006; 44:593-606.

Vigilance is required for Australia to remain polio free.

Thorley B, Brussen K, Elliott E, Kelly H.
Med J Aust 2006; 184:474-475.

Influenza surveillance in Victoria, 2005.

Turner J, Fielding J, Clothier H, Kelly H.
Commun Dis Intell 2006; 30:137-143.

Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor.

Yip M, Porter JL, Fyfe J, Lavender C, Porteals F, Rhodes M, Kator H, Colorni A, Jenkin GA, Stinear T. (2007)
J Bacteriol published online ahead of print 15 December 2006.